29
Views
0
CrossRef citations to date
0
Altmetric
Research Article

New (S)-verbenone-isoxazoline-1,3,4-thiadiazole Hybrids: Synthesis, Anticancer Activity and Apoptosis-Inducing Effect

, , , , , , , , , ORCID Icon & show all
Pages 1603-1619 | Received 09 Jun 2023, Accepted 08 Aug 2023, Published online: 29 Sep 2023

References

  • Organisation World Health (WHO) . Cancer (2020). www.who.int/news-room/fact-sheets/detail/cancer
  • Torre LA , BrayF , SiegelRLet al. Global cancer statistics, 2012. CA Cancer J. Clin.65(2), 87–108 (2015).
  • Youlden DR , CrambSM , DunnNAM , MullerJM , PykeCM , BaadePD. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol.36(3), 237–248 (2012).
  • Theodossiou TA , AliM , GrigalaviciusMet al. Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT–tamoxifen hybrid therapy. NPJ. Breast Cancer5(1) doi: 10.1038/s41523-019-0108-8, (2019) (Online).
  • Yang R , LiY , WangH , QinT , YinX , MaX. Therapeutic progress and challenges for triple negative breast cancer: targeted therapy and immunotherapy. Mol. Biomed.3(1)doi:10.1186/s43556-022-00071-6, (2022) (Online).
  • Jitariu A-A , CîmpeanAM , RibattiD , RaicaM. Triple negative breast cancer: the kiss of death the emerging concept of triple negative breast cancer. Oncotarget8(28), 46652–46662 (2017).
  • Reed JC . Dysregulation of apoptosis in cancer. J. Clin. Oncol.17(9), 2941–2953 (1999).
  • Wong RSY . Apoptosis in cancer: from pathogenesis to treatment. J. Exp. Clin. Cancer Res.30, 1–14 (2011).
  • Reed JC , TomaselliKJ. Drug discovery opportunities from apoptosis research. Pharm. Biotechnol.11, 586–592 (2000).
  • Cakir E , YilmazA , DemiragFet al. Prognostic significance of micropapillary pattern in lung adenocarcinoma and expression of apoptosis-related markers: caspase-3, BCL-2, and p53. APMIS119(9), 574–580 (2011).
  • Leung D , AbbenanteG , FairlieDP. Protease inhibitors: current status and future prospects. J. Medicinal Chem.43(3), 305–341 (2000).
  • Thornberry NA . Caspases: key mediators of apoptosis. Chem. Biol.5, R97–R103 (1998).
  • Clark AC , MacKenzieSH. Targeting cell death in tumors by activating caspases. Curr. Cancer Drug Targets8(2), 98–109 (2008).
  • Boudreau MW , PehJ , HergenrotherPJ. Procaspase-3 overexpression in cancer: a paradoxical observation with therapeutic potential. ACS Chem. Biol.14, 2335–2348 (2019).
  • Kaur K , KumarV , SharmaAK , GuptaGK. Isoxazoline containing natural products as anticancer agents: a review. Eur. J. Med. Chem.77, 121–133 (2014).
  • Simoni D , RobertiM , InvidiataFPet al. Heterocycle-containing retinoids. discovery of a novel isoxazole arotinoid possessing potent apoptotic activity in multidrug and drug-induced apoptosis-resistant cells. J. Medicinal Chem.44, 2308–2318 (2001).
  • Oubella A , BimoussaA , ByadiSet al. Cytotoxic and apoptotic effects of some (R)-carvone-isoxazoline derivatives on human fibrosarcoma and carcinoma cells: experimental evaluation for cytotoxicity, molecular docking and molecular dynamics studies. J. Biomol. Struct. Dyn.1–14 (2022).
  • Lingaraju GS , BalajiKS , JayaramaS , AnilSM , KiranKR , SadashivaMP. Synthesis of new coumarin tethered isoxazolines as potential anticancer agents. Bioorganic Med. Chem. Lett.28(23–24), 3606–3612 (2018).
  • Yan L , KuiH , Xu-FengL , Yu-LongL , Xing-HaiL , Zhong-QingJ. Diiron ethane-1, 2-dithiolate complexes with electrochemistry and fungicidal activity. Appl. Organomet. Chem.e6084(July), 1–9 (2020).
  • Mohamed AMM , IsmailMF , MadkourHMFet al. Straightforward synthesis of 2-chloro-N-(5-(cyanomethyl)-1,3,4-thiadiazol-2-yl)benzamide as a precursor for synthesis of novel heterocyclic compounds with insecticidal activity. Synth. Commun.50(22), 3424–3442 (2020).
  • Toolabi M , KhoramjouyM , AghcheliAet al. Synthesis and radioligand‐binding assay of 2, 5‐disubstituted thiadiazoles and evaluation of their anticonvulsant activities. Arch. Pharm.353(12), 2000066 (2020).
  • Türk S , SevgiK , AroomaM , EmineElçin O-E. Synthesis, characterization, antituberculosis activity and computational studies on novel Schiff bases of 1,3,4-thiadiazole derivatives. J. Res. Pharm.24(6), 793–800 (2020).
  • Vudhgiri S , DhevendarK , DileepKumar V , SunilM , PrasadRBN , RamChandra RJ. Synthesis and biological evaluation of 5-fatty-acylamido-1,3,4-thiadiazole-2-thioglycosides. Bioorg. Med. Chem. Lett.27(15), 3370–3373 (2017).
  • Revelant G , GadaisC , MathieuV , KirschG , HesseS. Synthesis and antiproliferative studies of 5-aryl-2-(3-thienylamino)-1,3,4-thiadiazoles. Bioorg. Med. Chem. Lett.24(12), 2724–2727 (2014).
  • Serban G . Synthetic compounds with 2-amino-1,3,4-thiadiazole moiety against viral infections. Molecules25, 942 (2020).
  • Othman AA , KihelM , AmaraS. 1,3,4-oxadiazole, 1,3,4-thiadiazole and 1,2,4-triazole derivatives as potential antibacterial agents. Arab. J. Chem.12(7), 1660–1675 (2014).
  • Haider S , AlamMS , HamidH. 1,3,4-Thiadiazoles: A potent multi targeted pharmacological scaffold. Eur. J. Med. Chem.92, 156–177 (2015).
  • Haider S , AlamMS , HamidH , DhulapA , KumarD. Design, synthesis and biological evaluation of benzoxazolinone-TNF-a inhibitors. Heliyon5(4), e01503 (2019).
  • Oubella A , ByadiS , BimoussaAet al. Novel isoxazoline-linked 1,3,4-thiadiazole hybrids as anticancer agents: design, synthesis, biological evaluation, molecular docking, and molecular dynamics simulation. Arch. Pharm. (Weinheim)355(9), 1–18 (2022).
  • Bimoussa A , OubellaA , BamouFZet al. New 1,3,4-thiadiazoles derivatives: synthesis, antiproliferative activity, molecular docking and molecular dynamics. Future Med. Chem.14(12), 881–897 (2022).
  • Khan I , ZaibS , IbrarA , RamaNH , SimpsonJ , IqbalJ. Synthesis, crystal structure and biological evaluation of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4- thiadiazines. Eur. J. Med. Chem.78, 167–177 (2014).
  • El-Gohary NS , ShaabanMI. Synthesis, antimicrobial, antiquorum-sensing, antitumor and cytotoxic activities of new series of fused [1,3,4]thiadiazoles. Eur. J. Med. Chem.63, 185–195 (2013).
  • Jung KY , KimSK , GaoZGet al. Structure-activity relationships of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists. Bioorganic Med. Chem.12(3), 613–623 (2004).
  • Hosseinzadeh L , KhorandA , AliabadiA. Discovery of 2‐phenyl‐N‐(5‐(trifluoromethyl)‐1,3,4‐thiadiazol‐2‐yl) acetamide derivatives as apoptosis inducers via the caspase pathway with potential anticancer activity. Arch. Pharm. (Weinheim)346(11), 812–818 (2013).
  • Mohammadi-farani A , HeidarianN , AliabadiA. Synthesis and in-vitro cytotoxicity evaluation as potential anticancer agents. Iran. J. Pharm. Res.13(September 2013), 487–492 (2014).
  • Rashdan HRM , FaragMM , El-GendeyMS , MounierMM. Toward rational design of novel anti-cancer drugs based on targeting, solubility, and bioavailability exemplified by 1,3,4-thiadiazole derivatives synthesized under solvent-free conditions. Molecules24(13), 1–17 (2019).
  • Boulhaoua M , PasinszkiT , TorviscoA , Oláh-SzabóR , BőszeS , CsámpaiA. Synthesis, structure and in vitro antiproliferative effects of alkyne-linked 1,2,4-thiadiazole hybrids including erlotinib- and ferrocene-containing derivatives. RSC Adv.11(46), 28685–28697 (2021).
  • Nepali K , SharmaS , SharmaM , BediPMS , DharKL. Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids. Eur. J. Med. Chem.77, 422–487 (2014).
  • Castro S De , María-JoséCamarasa. Polypharmacology in HIV inhibition: can a drug with simultaneous action against two relevant targets be an alternative to combination. Eur. J. Med. Chem.150, 206–227 (2018).
  • Fawzi M , OubellaA , ElMansouri AEet al. Novel hydrazono-2-iminothiazolidin-4-ones based on a monoterpenic skeleton as potential antitumor agents: synthesis, DFT Studies, in vitro cytotoxicity, apoptosis inducing properties and molecular docking. Chem. Biodivers.19(7), (2022).
  • Bimoussa A , FawziM , OubellaAet al. Hybrids of thiazolidinone with 1,2,3-triazole derivatives: design, synthesis, biological evaluation, in silico studies, molecular docking, molecular dynamics simulations, and ADMET profiling. J. Biomol. Struct. Dyn.0(0), 1–13 (2023).
  • Ousidi AN ai , BimoussaA , LoubidiMet al. Design, synthesis, cytotoxic effect evaluation and molecular docking of (R)-camphor-based thiazolidinone–isoxazole and thiazolidinone-1,2,3-triazole hybrids. Chemistry Select8(1), (2023).
  • Fawzi M , OubellaA , BimoussaAet al. Diastereomerically pure (S)‐verbenone‐isoxazoline hybrids: synthesis, molecular structure, hirshfeld surface analysis, DFT, cytotoxic effect and apoptosis induction. J. Heterocycl. Chem. (2022).
  • Krause L , Herbst-IrmerR , SheldrickGM , StalkeD. Comparison of silver and molybdenum microfocus x-ray sources for single-crystal structure determination. J. Appl. Crystallogr.48(1), 3–10 (2015).
  • Sheldrick GM . SHELXT - Integrated space-group and crystal-structure determination. Acta Crystallogr. Sect. A Found. Crystallogr.71(1), 3–8 (2015).
  • Brandenburg K , PutzH. Diamond. Cryst. Impact GbR, Bonn, Ger. (2006).
  • Fawzi M , OubellaA , BimoussaAet al. Diastereomerically pure (S)-verbenone-isoxazoline hybrids: Synthesis, molecular structure, Hirshfeld surface analysis, density functional theory, cytotoxic effect, and apoptosis induction. J. Heterocycl. Chem.60(2), 207–218 (2023).
  • Cremer D , PopleJA. A general definition of ring puckering coordinates. J. Am. Chem. Soc.97(6), 1354–1358 (1975).
  • Evans DG , BoeyensJCA. Conformational analysis of ring pucker. Acta Crystallogr. Sect. B Struct. Sci.45(6), 581–590 (1989).
  • Bimoussa A , KoumyaY , AbouelfidaAet al. Hemisynthesis, crystal structure and inhibitory effect of sesquiterpenic thiosemicarbazones and thiazolidin-4-ones on the corrosion behaviour of stainless steel in 1M H2SO4 solution. Acta Crystallogr. Sect. C Struct. Chem.75, 623–632 (2019).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.